A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin, Isabelle Fleury, Veronika Bachanova, S Ronan Foley, P Joy Ho, Stephan Mielke, John M Magenau, Harald Holte, Serafino Pantano, Lida B Pacaud, Rakesh Awasthi, Jufen Chu, Özlem Anak, Gilles Salles, Richard T Maziarz. N Engl J Med 2019
Times Cited: 972




List of shared articles



Times cited


Next-generation CAR T cells to overcome current drawbacks.
Stefan Lundh, Sayantan Maji, J Joseph Melenhorst. Int J Hematol 2021
2

Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.
Norihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, Masataka Suzuki. Mol Ther 2021
7

Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy.
Stella Bouziana, Dimitrios Bouzianas. Crit Rev Oncol Hematol 2021
2

Genetic engineering of T cells for immunotherapy.
Gavin I Ellis, Neil C Sheppard, James L Riley. Nat Rev Genet 2021
3


Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)-T Cells.
Ali Hosseini Rad S M, Joshua Colin Halpin, Mojtaba Mollaei, Samuel W J Smith Bell, Nattiya Hirankarn, Alexander D McLellan. Cancers (Basel) 2021
0

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
Ying Gong, Roel G J Klein Wolterink, Jianxiang Wang, Gerard M J Bos, Wilfred T V Germeraad. J Hematol Oncol 2021
2


A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Marie Thérèse Rubio, Pauline Varlet, Vincent Allain, Caroline Ballot, Alexis Cuffel, Marina Deschamps, Christophe Ferrand, Jacques Foguenne, Edouard Forcade, Anne Huynh,[...]. Bull Cancer 2021
0

Immunotherapies in Non-Hodgkin's Lymphoma.
Christine Bezombes, Patricia Pérez-Galán. Cancers (Basel) 2021
0


Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Bruno Martino, Maria Altomonte, Antonio Maria Rossetti, Giuseppa Cusumano, Letteria Russo,[...]. Expert Opin Biol Ther 2021
0

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy.
Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean-Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard,[...]. Cancers (Basel) 2021
0

Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh. Best Pract Res Clin Haematol 2021
0

Determinants of response and resistance to CAR T cell therapy.
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, Stefan Stoiber, Marion Subklewe, Stefan Endres, Sebastian Kobold. Semin Cancer Biol 2020
23

Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion.
Leonardo Chicaybam, Luiza Abdo, Mariana Viegas, Luisa Vieira Codeço Marques, Priscila de Sousa, Leonardo Ribeiro Batista-Silva, Viviane Alves-Monteiro, Simone Bonecker, Bárbara Monte-Mór, Martín Hernán Bonamino. Gene Ther 2020
11

Rapid and Effective Generation of Nanobody Based CARs using PCR and Gibson Assembly.
Stijn De Munter, Alexander Van Parys, Layla Bral, Joline Ingels, Glenn Goetgeluk, Sarah Bonte, Melissa Pille, Lore Billiet, Karin Weening, Annick Verhee,[...]. Int J Mol Sci 2020
5

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.
Sonia Guedan, Aviv Madar, Victoria Casado-Medrano, Carolyn Shaw, Anna Wing, Fang Liu, Regina M Young, Carl H June, Avery D Posey. J Clin Invest 2020
39